Kansas Moves to Expand Medicaid
As the vote on the American Health Care Act (AHCA) nears in Washington, DC, lawmakers in Kansas are moving forward with expanding Medicaid. According to The Wichita Eagle, Kansas state lawmakers crafted the expansion bill with an eye to AHCA, which would take away a provision that the federal government pays 90% of expansion costs. The Kansas bill would phase out Medicaid expansion if the federal match fell below 90%. Opponents say the bill should wait until a vote on AHCA, while supporters say they don’t want a decision in Washington to dictate healthcare in Kansas.
Trump Wants AHCA Vote Friday
On Thursday, House Speaker Paul Ryan, R-Wisconsin, delayed the vote on the Republican healthcare bill because it looked like the GOP didn’t have the votes to pass the bill. However, President Donald Trump won’t let the vote be postponed for long, reported The Washington Post. The president has delivered an ultimatum: vote on Friday or he’ll drop the healthcare debate and let the Affordable Care Act stand. Bringing the bill to the floor for a vote on Friday might result in it failing since negotiations with the conservative House Freedom Caucus fell through on Thursday.
CBO Issues Revised Score on Health Bill
Meanwhile, the Congressional Budget Office has revised its score on AHCA after taking into account amendments made at the beginning of the week. Politico reported that coverage under the amended bill would not change, but it would reduce the deficit by far less. The original report forecasted that the bill would reduce the deficit by $337 billion over 10 years, which Republicans held up in support of AHCA, but the CBO now says that the changes to the bill would mean it only reduces the deficit by $150 billion over 10 years.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More
Health Equity & Access Weekly Roundup: April 14, 2025
April 14th 2025From the potential impact of tariffs to the World Health Organization's year-long campaign launch focused on improving maternal and newborn health and addressing preventable deaths, here's the latest from the Center on Health Equity & Access.
Read More